Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

BacLite Rapid MRSA Clinical Performance

This study has been terminated.
(performance variability)
Sponsor:
Information provided by:
3M
ClinicalTrials.gov Identifier:
NCT00541632
First received: October 6, 2007
Last updated: May 14, 2008
Last verified: May 2008
  Purpose

The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.


Condition
Methicillin Resistance

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: BacLite Rapid MRSA Clinical Performance

Further study details as provided by 3M:

Study Start Date: October 2007
Study Completion Date: March 2008
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Subjects 18 years or older
  • Subjects willing to document demographic characteristics
  • Subjects willing to have their nose swabbed
  • Subjects (or legal representative) willing to sign consent and authorization forms

Exclusion Criteria:

  • Subjects who use Vicks Sinex Nasal spray or other nasal sprays
  • Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects
  • Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares
  • Investigator believes that subject is unsuitable for inclusion.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00541632

Locations
United States, Colorado
Denver Health Medical Center
Denver, Colorado, United States, 80204
United States, Georgia
Atlanta Institute for Medical Research, Inc.
Atlanta, Georgia, United States, 30030
United States, Illinois
Evanston Northwestern Healthcare
Evanston, Illinois, United States, 60201
United States, Iowa
University of Iowa
Iowa City, Iowa, United States, 52242
United States, Maryland
University of Maryland
Baltimore, Maryland, United States, 21201-1595
United States, Michigan
Wayne State University
Detroit, Michigan, United States, 48201
United States, Missouri
Washington University
St. Louis, Missouri, United States, 63110
United States, North Carolina
Wake Forest University
Winston-Salem, North Carolina, United States, 27157-1042
United States, Ohio
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Sponsors and Collaborators
3M
Investigators
Principal Investigator: Werner E Bischoff Wake Forest School of Medicine
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00541632     History of Changes
Other Study ID Numbers: 010737
Study First Received: October 6, 2007
Last Updated: May 14, 2008
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on November 24, 2014